Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 5
1989 2
1990 2
1991 3
1992 2
1993 2
1994 2
1996 1
1999 1
2001 4
2002 2
2003 2
2004 1
2005 5
2006 2
2007 1
2008 1
2009 3
2010 2
2013 1
2014 1
2015 2
2016 2
2018 1
2019 2
2020 6
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
Camostat mesilate therapy for COVID-19.
Uno Y. Uno Y. Intern Emerg Med. 2020 Nov;15(8):1577-1578. doi: 10.1007/s11739-020-02345-9. Epub 2020 Apr 29. Intern Emerg Med. 2020. PMID: 32347443 Free PMC article. No abstract available.
Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety.
Breining P, Frølund AL, Højen JF, Gunst JD, Staerke NB, Saedder E, Cases-Thomas M, Little P, Nielsen LP, Søgaard OS, Kjolby M. Breining P, et al. Basic Clin Pharmacol Toxicol. 2021 Feb;128(2):204-212. doi: 10.1111/bcpt.13533. Epub 2020 Nov 22. Basic Clin Pharmacol Toxicol. 2021. PMID: 33176395 Review.
Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.
Hoffmann M, Hofmann-Winkler H, Smith JC, Krüger N, Sørensen LK, Søgaard OS, Hasselstrøm JB, Winkler M, Hempel T, Raich L, Olsson S, Yamazoe T, Yamatsuta K, Mizuno H, Ludwig S, Noé F, Sheltzer JM, Kjolby M, Pöhlmann S. Hoffmann M, et al. bioRxiv. 2020 Aug 5:2020.08.05.237651. doi: 10.1101/2020.08.05.237651. Preprint. bioRxiv. 2020. PMID: 32793911 Free PMC article.
Camostat Mesylate May Reduce Severity of Coronavirus Disease 2019 Sepsis: A First Observation.
Hofmann-Winkler H, Moerer O, Alt-Epping S, Bräuer A, Büttner B, Müller M, Fricke T, Grundmann J, Harnisch LO, Heise D, Kernchen A, Pressler M, Stephani C, Tampe B, Kaul A, Gärtner S, Kramer S, Pöhlmann S, Winkler MS. Hofmann-Winkler H, et al. Crit Care Explor. 2020 Nov 16;2(11):e0284. doi: 10.1097/CCE.0000000000000284. eCollection 2020 Nov. Crit Care Explor. 2020. PMID: 33225308 Free PMC article.
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M, Shimotai Y, Hatachi Y, Lusamba Kalonji N, Tando Y, Kitajima Y, Matsuo K, Kubo H, Nagatomi R, Hongo S, Homma M, Nishimura H. Yamaya M, et al. Pulm Pharmacol Ther. 2015 Aug;33:66-74. doi: 10.1016/j.pupt.2015.07.001. Epub 2015 Jul 10. Pulm Pharmacol Ther. 2015. PMID: 26166259 Free PMC article.
62 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page